Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

Author: [email protected]

This author has written 1107 articles
  1. Home>
  2. [email protected]>
  3. Page 34

Windlas Biotech IPO Review

  • Post author:[email protected]
  • Post published:August 5, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

Windlas Biotech IPO comprises fresh issuance of equity shares worth ₹165 crore and an offer for sale of up to 5,142,067 equity shares ( ~ Rs. 236 crore) . Windlas Biotech…

Continue ReadingWindlas Biotech IPO Review

Exxaro Tiles IPO Review

  • Post author:[email protected]
  • Post published:August 5, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

Exxaro Tiles IPO intends to raise ₹161.09 crore public issue of the tile manufacturing company is going to open for subscription on 4th August 2021. The company promoters' have fixed…

Continue ReadingExxaro Tiles IPO Review

Krsnaa Diagnostics IPO Review

  • Post author:[email protected]
  • Post published:August 4, 2021
  • Post category:Uncategorized
  • Post comments:0 Comments

Krsnaa Diagnostics Ltd has fixed a price band of ₹933-954 a share for its initial public offer (IPO). The IPO will open for subscription on 4 August and close on 6…

Continue ReadingKrsnaa Diagnostics IPO Review

Devyani International IPO Review

  • Post author:[email protected]
  • Post published:August 3, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

Devyani International IPO of Rs.1,838 crore comprises of Rs.440 crore by way of new issue and Rs.1,398 crore by way of offer for sale (up to 155.33 million shares). Devyani…

Continue ReadingDevyani International IPO Review

Rolex Rings IPO: Consolidated Brokerage Views

  • Post author:[email protected]
  • Post published:July 29, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Rolex Rings IPO attempts to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingRolex Rings IPO: Consolidated Brokerage Views

Glenmark Life Sciences IPO: Brokerage Views

  • Post author:[email protected]
  • Post published:July 28, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Glenmark Life Sciences IPO attempts to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated…

Continue ReadingGlenmark Life Sciences IPO: Brokerage Views

Rolex Rings IPO Review

  • Post author:[email protected]
  • Post published:July 28, 2021
  • Post category:Uncategorized
  • Post comments:0 Comments

Rolex Rings IPO comprises a fresh issue of shares worth ₹56 crore and an offer for sale of up to 75 lakh equity stocks by Rivendell PE LLC (formerly known as…

Continue ReadingRolex Rings IPO Review

Glenmark Life Sciences IPO

  • Post author:[email protected]
  • Post published:July 27, 2021
  • Post category:Uncategorized
  • Post comments:0 Comments

Glenmark Life Sciences IPO plans to raise Rs 1514 cr which comprises of Rs 454 cr offer for sale and Rs 1060 cr. fresh issue of equity shares. Glenmark Life…

Continue ReadingGlenmark Life Sciences IPO

Tatva Chintan Pharma IPO: Brokerage Views

  • Post author:[email protected]
  • Post published:July 16, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Tatva Chintan Pharma IPO attempts to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated…

Continue ReadingTatva Chintan Pharma IPO: Brokerage Views

Tatva Chintan Pharma IPO

  • Post author:[email protected]
  • Post published:July 16, 2021
  • Post category:Uncategorized
  • Post comments:0 Comments

Tatva Chintan Pharma IPO intends to raise Rs. 500 crore through fresh issue of shares worth Rs 225 crore and an offer for sale of shares worth Rs 275 crore…

Continue ReadingTatva Chintan Pharma IPO

Zomato IPO: Consolidated Brokerage Views

  • Post author:[email protected]
  • Post published:July 14, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Zomato IPO attempts to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from various…

Continue ReadingZomato IPO: Consolidated Brokerage Views

Zomato IPO Review

  • Post author:[email protected]
  • Post published:July 14, 2021
  • Post category:IPO Review
  • Post comments:0 Comments

Food delivery giant Zomato IPO seeks to raise Rs 9,375-crore through its initial public offering and will be the largest in last sixteen months since the SBI Card IPO. ,…

Continue ReadingZomato IPO Review
  • Go to the previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 93
  • Go to the next page

Archives

Categories

Copyright - WordPress Theme by OceanWP